Europe’s IPC market heats up as Taiwanese firms battle Chinese price pressure
The industrial computer (IPC) sector faced a turbulent 2024 amid global economic and geopolitical uncertainties, leading to reduced inventories, order…
Taiwan’s submarine cable cut near China raises gray-zone concerns, again
Taiwan’s digital infrastructure faced challenges again as two submarine cables connecting Taiwan and the Matsu Islands were completely severed on…
Mitsubishi Electric to ramp up R&D, eyeing EPCI, quantum, and hydrogen technologies
On January 15, Mitsubishi Electric unveiled its updated R&D strategy, highlighting its commitment to advancing technologies like electronic-photonic converging integration…
Samsung Electro-Mechanics, SoulBrain to develop next-gen glass substrates, mass production set for 2027
Samsung Electro-Mechanics is teaming up with South Korean semiconductor materials company SoulBrain to develop materials for glass substrates, with plans…
Taiwan advances academic research in quantum technology and materials amid global race
While Nvidia CEO Jensen Huang’s recent comments at CES 2025–suggesting it may take at least 20 years to develop a…
China’s GPU IPO momentum continues: MetaX prepares for A-share listing
On January 16, 2025, reports emerged that Muxi Integrated Circuit Co., Ltd. (MetaX), a Chinese GPU manufacturer, entered the IPO…
LCD panel industry faces further consolidation under Trump
Industry observers anticipate accelerated consolidation among second-tier LCD panel makers as US President Donald Trump prepares to implement new trade…
Trump to prioritize US auto manufacturing despite challenges
President Donald Trump has returned to the White House, and in his inaugural speech, he reaffirmed his commitment to manufacturing…
PTI sees memory backend demand start recovering in 2Q25
Backend house Powertech Technology (PTI) anticipates a resurgence in demand from the memory sector beginning in the second quarter, with…
Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication – FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis
The FDA is warning about the risk of a rare but serious allergic reaction with the medicine glatiramer acetate (Copaxone,…